Alset is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology, and biohealth activities with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The company manages its three principal businesses primarily through its subsidiary, Alset International Limited (formerly known as “Singapore eDevelopment Limited”), a public company traded on the Singapore Stock Exchange. Through this subsidiary (and indirectly, through other public and private U.S. and Asian subsidiaries), the company is actively developing two significant real estate projects near Houston, Texas, and in Frederick, Maryland, in the property development segment. The company has designed applications for enterprise messaging and e-commerce software platforms in the United States and Asia in the digital transformation technology business unit. The company’s recent foray into the biohealth segment primarily includes research to treat neurological and immune-related diseases, nutritional chemistry to create a natural sugar alternative, research regarding innovative products to slow the spread of disease, and certain natural foods and supplements.
